RxDoctor Payments Data

Krishna Cidambi, MD

Adult Reconstructive Orthopaedic Surgery · San Diego, CANPI 1275836959

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $44,651 of the $50,620 with a category attached, or 88.2%. Medical Device Business Services, Inc. accounts for 91.8% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2023 at $14,299 and has fallen 96.3% since, to $527 in 2025.

$50,620in general payments, 2019–2025

Across 87 payments — averaging $581.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$46K
  • Zimmer Biomet$1K
  • Stryker$808
  • Johnson & Johnson$737
  • Corin USA$597
  • Encore Medical, LP$342
  • plus $465 from 10 others

What the payments were for

  • Consulting fees$44,65188%
  • Travel & lodging$1,7243%
  • Food & beverage$4,0718%
  • Education$1740%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$50,620 in reported general payments places this provider in the 70th percentile of 136 adult reconstructive orthopaedic surgery providers in California.

See all adult reconstructive orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$114,465
Medicare patients
154
Services billed
300

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib18$614
Gabapentin25$201
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$135
Amoxicillin20$16

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →